Indian Gemcitabine Exporters: Complete Supplier Ranking with Market Share — 676 Manufacturers (2026) — TransData Nexus

Q: Who is the largest gemcitabine buyer importing from India?

YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the largest gemcitabine importer from India with a 10.9% market share and import value of $5.1M.

Q: How many gemcitabine buyers import from India?

There are 676 active gemcitabine buyers importing from India, with a combined import market of $46.5M across 2,938 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top gemcitabine buyers from India?

The top 5 gemcitabine buyers — YUSEN LOGISTICS BENELUX BELGIUM, EUGIA PHARMA (MALTA) LTD,, MYLAN INSTITUTIONAL INC 2898, PHARMACIE CENTRALE DES HOPITAUX, FRESENIUS KABI DEUTSCHLAND GMBH — together control 31.3% of total gemcitabine import value from India.

Suresh Sormare

Gemcitabine

India Pharmaceutical Trade Intelligence

$46.5M248 Suppliers125 CountriesHS 30049049

ExportsIndia → UNITED STATES16.8%India → BELGIUM12.7%

ImportsUNITED STATES → India$133.8M FRANCE → India$35.5M

#1 Supplier: FRESENIUS KABI #1 Buyer: YUSEN LOGISTICS

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $7.8M through 47 shipments. This represents a market share of 16.8% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• MYLAN INSTITUTIONAL INC 2898 - $2.5M (31.5% of country's total business)

• MYLAN INSTITUTIONAL INC - $1.2M (16.0% of country's total business)

• EVERSANA LIFE SCIENCES SERVICES,LLC - $946.8K (12.1% of country's total business)

• AMERISOURCE HEALTH SERVICES - $920.4K (11.8% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $166.1K, indicating premium pricing strategy compared to the market average of $15.8K.

United States is a key market for Gemcitabine imports, representing 16.8% of total trade value.

Primary Market

Secondary Market

2Belgium

Buyer Segment Analysis

TransData Nexus Gemcitabine buyer market intelligence

1Buyer Segment Analysis

Our data indicates that Gemcitabine exports from India amounted to $46.5 million across 2,938 shipments, involving 248 exporters and 676 buyers spanning 125 importing countries. The repeat buyer rate stands at 60.4%, suggesting a stable demand base.

Buyer Segments:

1. Distributors: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $5.07M) and EUGIA PHARMA (MALTA) LTD (Malta, $3.37M) function as intermediaries, procuring large volumes to supply regional markets. Their purchasing patterns are characterized by bulk orders aligned with market demand forecasts.

2. Hospital Groups: Organizations such as PHARMACIE CENTRALE DES HOPITAUX (Algeria, $2.10M) represent centralized procurement bodies for hospital networks, focusing on consistent supply to meet patient needs. Their orders are typically regular and substantial, ensuring uninterrupted treatment availability.

3. Government Procurement Agencies: Entities like FRESENIUS KABI DEUTSCHLAND GMBH (Germany, $1.58M) may engage in tender-based purchasing for public healthcare systems, emphasizing cost-effectiveness and quality assurance. Their procurement processes are often periodic, following structured tender cycles.

4. Re-exporters: Companies such as XXIZEXXSERXXCE XXMPAXX BV (Czech Republic, $1.38M) may act as re-exporters, importing Gemcitabine for redistribution to neighboring regions, leveraging logistical advantages. Their buying behavior is influenced by regional demand fluctuations and trade agreements.

5. Contract Manufacturers: Firms like MYLAN INSTITUTIONAL INC (United States, $2.46M) and OOO JODAS EXPOIM (Russia, $1.19M) may procure Gemcitabine as active pharmaceutical ingredients (APIs) for formulation into finished products. Their orders are typically aligned with production schedules and regulatory approvals.

Country-Specific Import Regulations

TransData Nexus Gemcitabine buyer market intelligence

1Country-Specific Import Regulations

United States:

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Gemcitabine is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.

3. Estimated Timeline: The FDA review process for NDAs typically takes 10 months, while ANDAs may take 8-10 months.

4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are generally duty-free in the United States.

Belgium:

1. Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).

2. Import Registration Process: Importers must obtain a marketing authorization from FAMHP, which includes submitting a dossier demonstrating the product's quality, safety, and efficacy.

3. Estimated Timeline: The evaluation process can take up to 210 days, excluding clock stops for additional information requests.

4. Import Tariff/Duty: As an EU member state, Belgium applies a 0% tariff on pharmaceutical products under HS Code 30049049.

Malta:

1. Regulatory Authority: Malta Medicines Authority (MMA).

2. Import Registration Process: Importers must apply for a marketing authorization, providing comprehensive data on the product.

3. Estimated Timeline: The process typically takes 210 days, in line with EU directives.

4. Import Tariff/Duty: Malta, as an EU member, imposes a 0% tariff on pharmaceutical imports under HS Code 30049049.

Algeria:

1. Regulatory Authority: Agence Nationale des Produits Pharmaceutiques (ANPP).

2. Import Registration Process: Importers must obtain a registration certificate from ANPP, involving the submission of a technical dossier and compliance with local regulations.

Demand Drivers & Market Opportunity

TransData Nexus Gemcitabine buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Gemcitabine is primarily driven by its efficacy in treating various cancers, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer. The global incidence of these cancers has been rising, necessitating increased access to effective chemotherapy agents.

Government healthcare programs and the expansion of universal health coverage have significantly influenced Gemcitabine procurement. Many countries include Gemcitabine in their national essential medicines lists, aligning with the World Health Organization's Essential Medicines List, which emphasizes the importance of accessible cancer treatments. Tender-based purchasing is a common procurement strategy, ensuring cost-effective and equitable access to essential medicines. Our data, indicating 676 buyers across 125 countries, reflects the widespread adoption of such procurement practices.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Gemcitabine Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest gemcitabine buyer importing from India?

Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $5.1M in imports and a 10.9% market share — the highest of any single gemcitabine importer. EUGIA PHARMA (MALTA) LTD, (MALTA) and MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) are the next largest buyers.

QHow many companies buy gemcitabine from India?

There are 676 active gemcitabine buyers importing from India, with a combined market of $46.5M across 2,938 shipments to 125 countries. The top 5 buyers hold 31.3% of total import value, while the remaining 671 buyers handle the other 68.7%.

QWhich countries import the most gemcitabine from India?

The top importing countries for gemcitabine from India are United States (16.8%), Belgium (12.7%), Malta (11.6%), Algeria (7.6%), Russia (6.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of gemcitabine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for gemcitabine from India?

The average import transaction value for gemcitabine from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Gemcitabine buyer market intelligence

1Buyer Segment Analysis

Buyer Segments:

Country-Specific Import Regulations

TransData Nexus Gemcitabine buyer market intelligence

1Country-Specific Import Regulations

United States:

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline: The FDA review process for NDAs typically takes 10 months, while ANDAs may take 8-10 months.

4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are generally duty-free in the United States.

Belgium:

1. Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).

2. Import Registration Process: Importers must obtain a marketing authorization from FAMHP, which includes submitting a dossier demonstrating the product's quality, safety, and efficacy.

3. Estimated Timeline: The evaluation process can take up to 210 days, excluding clock stops for additional information requests.

4. Import Tariff/Duty: As an EU member state, Belgium applies a 0% tariff on pharmaceutical products under HS Code 30049049.

Malta:

1. Regulatory Authority: Malta Medicines Authority (MMA).

2. Import Registration Process: Importers must apply for a marketing authorization, providing comprehensive data on the product.

3. Estimated Timeline: The process typically takes 210 days, in line with EU directives.

4. Import Tariff/Duty: Malta, as an EU member, imposes a 0% tariff on pharmaceutical imports under HS Code 30049049.

Algeria:

1. Regulatory Authority: Agence Nationale des Produits Pharmaceutiques (ANPP).

2. Import Registration Process: Importers must obtain a registration certificate from ANPP, involving the submission of a technical dossier and compliance with local regulations.

Demand Drivers & Market Opportunity

TransData Nexus Gemcitabine buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Gemcitabine

Gemcitabine

Who Buys Gemcitabine from India — 676 Importers Behind a $46.5M Market

Top Gemcitabine Importers — Ranked by Import Value

Top Gemcitabine Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Gemcitabine — and from which countries?

Gemcitabine — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

2Belgium

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Gemcitabine Buyers & Importers

QWho is the largest gemcitabine buyer importing from India?

QHow many companies buy gemcitabine from India?

QWhich countries import the most gemcitabine from India?

QWhat is the average import order value for gemcitabine from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Malta

4Algeria

5Russia

Analysis Methodology